Banca Monte dei Paschi di Siena (OTCPK:BMDPF)
$ 12.21 -0.15 (-1.25%) Market Cap: 37.50 Bil Enterprise Value: 79.08 Bil PE Ratio: 9.12 PB Ratio: 1.16 GF Score: 43/100

Q3 2025 Banca Monte dei Paschi di Siena SpA Earnings Call Transcript

Nov 07, 2025 / 08:00AM GMT
Release Date Price: $8.71

Key Points

Positve
  • Banca Monte dei Paschi di Siena (BMDPF) successfully completed the acquisition of Medibanka, with 86.3% of shareholders tendering their shares, indicating strong support for the merger.
  • The company reported a net profit of approximately €1.4 billion, up by 70.5% excluding net taxes, showcasing strong financial performance.
  • The bank's capital position is robust, with a common equity tier one ratio of 16.9%, providing strategic flexibility.
  • Banca Monte dei Paschi di Siena (BMDPF) has set new guidance for pre-tax profit to exceed €1.6 billion for the full year 2025.
  • The bank demonstrated strong commercial performance, with significant growth in mortgages and consumer loans, indicating a deep connection with clients and the real economy.
Negative
  • The integration process with Medibanka involves complex restructuring, with over 20 ongoing work streams, which could pose challenges.
  • There is uncertainty regarding the impact of the purchase price allocation (PPA) on the capital position, as it is still under assessment.
  • The bank faces potential challenges in maintaining its dividend policy amidst changes in capital requirements and tax implications.
  • The impact of the new bank tax law is expected to be around €100 million per year, which could affect profitability.
  • There is a need for careful management of integration charges and restructuring costs, which could impact financial results in the short term.
Luigi Lovaglio
Banca Monte dei Paschi di Siena SpA - Chief Executive Officer, General Manager, Executive Director

Good morning everyone.

Thank you for joining us today for the presentation of our 3rd quarter and 9 months 2025 financial results.

This is a landmark moment for Monte Pasque.

At the end of September we successfully completed the acquisition of Medibanka, a strategic move we have always believed in.

And 86.3% of Medibankca shareholders confirm that belief by tendering their shares.

That's a clear endorsement of the industrial strength and the long-term value of this combination from bothk shareholders and from Italian and international institutional investors.

So first, let me thank all of our shareholders for their trust and confidence in our vision, in our ability to execute.

I also want to thank our people.

Our teams at Montepaschi have stayed laser focused through intense months, and they continue to serve clients, deliver a strong commercial momentum, and produce another solid quarter.

They showed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot